CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 120 enrolled
Drug / intervention
Zoladexdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01682642
NCT01682642Phase 4Completed

IVF Outcome in Patients With Peritoneal Endometriosis. The Impact of a Hormonal Treatment of the Endometriosis Prior to the IVF on the Pregnancy Rates.

AZ Jan Palfijn Gent·interventional·Posted Sep 11, 2012·Updated Mar 20, 2015

In Brief

A Phase 4 clinical trial evaluating Zoladex for Infertility and Endometriosis. Completed, enrolled 120 participants across 1 site.

Detailed Summary

In this study of endometriosis patients we compare a common treatment of surgical therapy and medical treatment for 3 months (Zoladex) with patients receiving only surgical therapy. In both cases they immediately start In Vitro Fertilization (IVF) treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesBelgium

Timeline

Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedSep 11, 2012
Enrollment StartMar 1, 2012
Primary CompletionOct 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 13.8 years ago

Interventions

Zoladexdrug

after surgical vaporization patients are treated with Zoladex for 3 months before starting IVF treatment